Pharma Foods International Co.,Ltd. (2929.T) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	66.4B	65.3B	62.1B	68.6B	60.2B
Cost of Revenue	3.1B	12.7B	13.4B	13.3B	12.1B
Gross Profit	12.6B	52.6B	48.8B	55.3B	48.1B
Operating Expenses
R&D Expense	—	—	—	—	—
SG&A Expense	15.1B	50.2B	43.6B	51.7B	47.0B
General & Admin Expense	—	—	—	—	—
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	—	—	—	—	—
Total Operating Expenses	15.1B	50.2B	43.6B	51.7B	47.0B
Cost and Expenses	67.4B	62.9B	57.0B	65.0B	59.1B
Operating Income (EBIT)	(1.0B)	2.4B	5.1B	3.6B	1.1B
Non-Operating
Interest Income	8.0M	6.0M	1.0M	1.0M	2.0M
Interest Expense	25.0M	91.0M	62.0M	48.0M	26.0M
Net Interest Income	(17.0M)	(85.0M)	(61.0M)	(47.0M)	(24.0M)
Other Non-Op Income/Expense	(133.0M)	186.0M	135.0M	(70.0M)	185.0M
Non-Operating Income (excl Interest)	55.0M	466.0M	284.0M	168.0M	226.0M
EBT (Pre-Tax Income)	(2.6B)	2.4B	5.0B	3.5B	1.4B
Income Tax Expense	(749.0M)	2.1B	1.8B	462.0M	1.8B
Bottom Line
Net Income	(1.9B)	368.0M	3.2B	3.1B	(374.0M)
Earnings from Cont. Ops	—	—	—	—	—
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	(1.9B)	368.0M	3.2B	3.1B	(374.0M)
Per Share
Basic EPS	(¥65)	¥13	¥113	¥107	(¥13)
Diluted EPS	(¥65)	—	—	—	—
Revenue Per Share	¥2,299	¥2,271	¥2,185	¥2,375	¥2,074
Shares
Basic Shares Outstanding	28.9M	28.7M	28.4M	28.9M	29.0M
Diluted Shares Outstanding	—	—	—	—	—
Profitability Metrics
EBITDA	(2.4B)	3.1B	5.9B	4.1B	1.5B
D&A	158.0M	732.0M	808.0M	474.0M	469.0M
EBIT	(1.0B)	2.4B	5.1B	3.6B	1.1B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jan 1, 2026